NCT05694091

Brief Summary

In view of the increasingly severe aging situation in China, the perioperative brain health of elderly patients has received increasing attention. Postoperative delirium (POD) is a common postoperative complication characterized by acute consciousness and cognitive dysfunction. The incidence of POD in elderly patients undergoing elective non cardiac surgery is 20%\~45%, which often indicates poor cognitive recovery and becomes a heavy burden for family and society. Although the weight of human brain only accounts for 2% of body weight, the oxygen consumption accounts for 20% of the total oxygen consumption of the whole body. On July 2, 2022, the British Journal of Anaesthesia (Chinese Academy of Sciences Division 1, Anesthesiology Division 1, IF11.719), the top international Journal in the field of anesthesiology, published the scientific research achievements of the first author of the applicant. It was found for the first time that sevoflurane, the most commonly used inhalation anesthetic in clinical practice, can cause the activation of glycolysis and the increase of lactic acid in the brain of elderly non-human primate marmosets, which suggests that general anesthetics will affect brain metabolism in the perioperative period. Therefore, we hypothesized that perioperative changes in brain metabolism might be related to the occurrence of POD in elderly patients. The purpose of this study was to study the relationship between the changes of brain metabolites and POD during perioperative period by noninvasive monitoring of the characteristics of brain tissue metabolites 24 hours before and 24 hours after the operation with hydrogen ion proton magnetic resonance spectroscopy (1-HMRS). In order to complete this purpose, this study plans to collect subjects aged 65\~90 years who are scheduled to undergo oral and maxillofacial surgery under general anesthesia. The changes of brain metabolites before and after operation were collected by 1-HMRS, and the postoperative delirium related scale was evaluated to analyze the relationship between perioperative changes of brain metabolites and POD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 18, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 23, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 6, 2023

Status Verified

November 1, 2022

Enrollment Period

3 years

First QC Date

January 12, 2023

Last Update Submit

July 3, 2023

Conditions

Outcome Measures

Primary Outcomes (7)

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    1 day after surgery

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    2 day after surgery

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    3 day after surgery

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    4 day after surgery

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    5 day after surgery

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    6 day after surgery

  • 3D-CAM (3-minute Diagnostic Interview for Confusion Assessment Method) scale

    3D-CAM higher means worse

    7 day after surgery

Secondary Outcomes (6)

  • MOCA(Montreal Cognitive Assessment) scale

    1 day after surgery

  • MOCA(Montreal Cognitive Assessment) scale

    3 day after surgery

  • MOCA(Montreal Cognitive Assessment) scale

    7 day after surgery

  • MMSE (mini-mental state examiniation) scale

    1 day after surgery

  • MMSE (mini-mental state examiniation) scale

    3 day after surgery

  • +1 more secondary outcomes

Study Arms (2)

Patients in the control group were followed up without delirium postoperatively.

If the 3D-CAM scale all show a negative resluts

Other: Collecting clinical data, blood gas data, Magnetic Resonance Spectroscopy (MRS) data and blood,urine, and feces sample

Patients in the case group were followed up with delirium postoperatively.

If the 3D-CAM assessment is positive at any time point after surgery

Other: Collecting clinical data, blood gas data, Magnetic Resonance Spectroscopy (MRS) data and blood,urine, and feces sample

Interventions

Collecting clinical data(before induction of anesthesia and first day after surgery), blood gas data(before induction of anesthesia and first day after surgery) ,MRS data (not more than 24h after surgery)and blood,urine, and feces sample (before induction of anesthesia and first day, third day and 7th day after surgery)

Patients in the case group were followed up with delirium postoperatively.Patients in the control group were followed up without delirium postoperatively.

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Our research is a single center, nested case-control study. Preoperatively collect the information of the elderly patients 65-90 years old without undergoing craniocerebral operations, including the vital signs, the examination reports and other related data after excluding the factors that can't be included in the group. The patients' health scales and delirium scales were evaluated.

You may qualify if:

  • The ASA grade of the subject is Ⅰ - Ⅲ;
  • years old;
  • Oral craniomaxillofacial surgery under combined general anesthesia

You may not qualify if:

  • The following medical devices have been installed in the body or are to be installed or implanted in the hospital: various cardiac pacemakers; Metal implants (non titanium), ferromagnetic vascular clips in the body
  • The patient is left-handed;
  • Patients with claustrophobia;
  • People with vision and hearing impairment, illiterate or difficult to communicate;
  • The operation plan includes patients with tracheotomy or postoperative catheterization;
  • Refusing to sign the clinical trial consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai 9Th Hospital

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

MeSH Terms

Interventions

Magnetic Resonance SpectroscopyBlood Specimen CollectionUrination

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative TechniquesSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeUrinary Tract Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Officials

  • Hong Jiang, Doctor

    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    STUDY DIRECTOR

Central Study Contacts

Ren Zhou, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2023

First Posted

January 23, 2023

Study Start

November 18, 2022

Primary Completion

December 1, 2025

Study Completion

December 31, 2025

Last Updated

July 6, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations